News

Eiger BioPharmaceuticals to Present at Jefferies 2017 Global Healthcare Conference June 7th

PALO ALTO, Calif., May 30, 2017 /PRNewswire/ —¬†Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today that David Cory, President and CEO of Eiger, will present a corporate overview and business update at the Jefferies 2017 Global Healthcare Conference at 11:00 am ET on Wednesday, June 7, 2017, in New York City.

2017-06-27T12:17:42+00:00